Carole Ho - Chief Medical Officer, Denali Therapeutics Inc

As of August 25, 2021


Carole Ho Net Worth

  • Net worth is estimated to be at least $8.93M
  • Owns at least 183,630 units of Denali Therapeutics Inc stock
  • Sold an estimated value of $8.93M in the last 3 years at Denali Therapeutics Inc

Carole Ho Compensation at Denali Therapeutics Inc in 2020

  • Earned a $457,600 salary and a $366 bonus
  • Rewarded $1,382,774 in stock value and options
  • Received a total compensation of $4,325,347

Carole Ho Trading

  • Largest purchase of shares was 52,906 units , worth over $279.34K on October 13, 2020
  • Largest sale of shares was 52,906 units , worth over $2.16M on October 13, 2020
  • In total has made about 32 transactions over 3 years
  • Usually trades in August, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Carole Ho Mailing Address

  • Mailing address is C/o Denali Therapeutics Inc. 151 Oyster Point Blvd., 2nd Floor South San Francisco CA 94080 CA

Denali Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Ryan J. Watts, Ph.D. 2020 $589,472 $648,419 $2,596,305 $5,456,849 $11,400 $9,302,445
Ryan J. Watts, Ph.D. 2019 $566,800 $311,740 $838,168 $3,252,452 $9,447 $4,978,607
Ryan J. Watts, Ph.D. 2018 $545,000 $524,563 $ $4,914,360 $ $5,983,923
Alexander O. Schuth, M.D. 2020 $449,400 $359,520 $1,364,638 $2,018,444 $11,400 $4,203,402
Alexander O. Schuth, M.D. 2019 $428,000 $171,200 $305,830 $1,558,941 $12,657 $2,476,628
Alexander O. Schuth, M.D. 2018 $400,000 $355,000 $179,673 $2,948,616 $18,500 $3,901,789
Steve E. Krognes 2020 $484,200 $387,362 $1,364,638 $2,018,444 $11,400 $4,266,044
Steve E. Krognes 2019 $470,057 $188,023 $305,830 $1,558,941 $7,834 $2,530,685
Steve E. Krognes 2018 $455,260 $393,682 $179,673 $2,948,616 $24,000 $4,001,231
Carole Ho, M.D. 2020 $457,600 $366,080 $1,382,774 $2,107,493 $11,400 $4,325,347
Carole Ho, M.D. 2019 $440,000 $176,000 $305,830 $1,558,941 $8,800 $2,489,571
Carole Ho, M.D. 2018 $423,124 $371,187 $179,673 $2,948,616 $12,869 $3,935,469
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1714899/000171489921000042/fy20def14aproxy.htm

Denali Therapeutics Inc Insider Trading

  • The most recent transaction was 10,000 units sold on October 6, 2021 by Alexander Schuth worth over $505.6K
  • In the last 4 years, insiders at Denali Therapeutics Inc sold an estimated value of $428.17M and bought an estimated value of $7.55M
  • The most active traders are Alexander Schuth, COO and Secretary,  Ryan Watts, President and CEO,  and Carole Ho, Chief Medical Officer
  • Insider trading is most common in June, with the busiest year in 2021

Denali Therapeutics Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1